This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MAXWELL FINLAND, M.D.; HARRY F. DOWLING, M.D.

Arch Intern Med. 1936;58(4):598-619.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The separation of types among the pneumococci previously included in group IV¹ has made it possible properly to classify pneumococci from practically all sources,² thus affording a more rational attack on various epidemiologic,³ immunologic⁴ and clinical⁵ aspects of pneumococcic infections and their specific treatment.⁶ It has made possible also the segregation of pneumococci previously recognized primarily because of their relationship to other types.⁷ The antibody response to infections with such related types and the immunologic reactions of normal human subjects to these pneumococci have already received some attention.⁸ The clinical and bacteriologic features of the disease produced by type III and the related type VIII pneumococci have been reported from two different clinics.⁹ This paper deals with the more important features of infections with type II and the related type V pneumococci, with especial reference to pneumonia.

The type II pneumococcus ranks second or third in frequency as a . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON; WASHINGTON, D. C.

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School.

Footnotes
This study was aided, in part, by a grant given in memory of Francis Weld Peabody by the Ella Sachs Plotz Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?